Furthermore, dysregulated the MEK5-ERK5 axis is associated with tumor growth, invasion, metastasis, poor prognosis, and therapeutic resistance in various tumor types such as breast cancer, prostate cancer, colon cancer, and lung cancer (14–19). Here, MAPK7 is linked to neoplasm.